GRDN (STOCKS)
Guardian Pharmacy Services, Inc.
$34.590000
+0.790000 (+2.34%)
Prev close: $33.800000
Company Information
- Exchange
- XNYS
- Sector
- Retail Trade
- Industry
- Drugstore Chains
- CEO
- Fred Burke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,191.84M
- Employees
- 3,400
- P/E (TTM)
- 53.10
- P/B (TTM)
- 11.65
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.15 | $0.17 | -0.0234 | -13.49% |
|
Jun 2025 (Q2)
|
$0.14 | $0.16 | -0.0181 | -11.45% |
|
Mar 2025 (Q1)
|
$0.15 | $0.18 | -0.0336 | -18.30% |
|
Dec 2024 (Q4)
|
$0.19 | $0.17 | +0.0217 | +12.89% |
Financial Statements
| Revenues | $1.39B |
| Benefits Costs and Expenses | $1.33B |
| Cost Of Revenue | $1.12B |
| Costs And Expenses | $1.33B |
| Gross Profit | $274.32M |
| Nonoperating Income/Loss | -$149.00K |
| Operating Expenses | $215.63M |
| Selling, General, and Administrative Expenses | $215.63M |
| Operating Income/Loss | $58.69M |
| Income/Loss From Continuing Operations After Tax | $39.53M |
| Income/Loss From Continuing Operations Before Tax | $58.55M |
| Income Tax Expense/Benefit | $19.01M |
| Net Income/Loss | $39.53M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$705.00K |
| Net Income/Loss Attributable To Parent | $40.24M |
| Net Income/Loss Available To Common Stockholders, Basic | $40.24M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $390.04M |
| Current Assets | $198.28M |
| Inventory | $47.86M |
| Other Current Assets | $150.42M |
| Noncurrent Assets | $191.76M |
| Fixed Assets | $56.12M |
| Intangible Assets | $18.92M |
| Other Non-current Assets | $116.72M |
| Liabilities | $194.54M |
| Current Liabilities | $161.95M |
| Accounts Payable | $121.68M |
| Wages | $15.94M |
| Other Current Liabilities | $24.33M |
| Noncurrent Liabilities | $32.59M |
| Equity | $195.50M |
| Equity Attributable To Noncontrolling Interest | $11.74M |
| Equity Attributable To Parent | $183.76M |
| Liabilities And Equity | $390.04M |
| Net Cash Flow From Operating Activities | $87.99M |
| Net Cash Flow From Operating Activities, Continuing | $87.99M |
| Net Cash Flow From Investing Activities | -$34.14M |
| Net Cash Flow From Investing Activities, Continuing | -$34.14M |
| Net Cash Flow From Financing Activities | -$54.59M |
| Net Cash Flow From Financing Activities, Continuing | -$54.59M |
| Net Cash Flow | -$734.00K |
| Net Cash Flow, Continuing | -$734.00K |
| Comprehensive Income/Loss | $39.53M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $39.53M |
| Other Comprehensive Income/Loss | $0.00 |